407 related articles for article (PubMed ID: 17205078)
21. Platelet aging in vivo is associated with activation of apoptotic pathways: studies in a model of suppressed thrombopoiesis in dogs.
Pereira J; Soto M; Palomo I; Ocqueteau M; Coetzee LM; Astudillo S; Aranda E; Mezzano D
Thromb Haemost; 2002 May; 87(5):905-9. PubMed ID: 12038796
[TBL] [Abstract][Full Text] [Related]
22. ABT-737 Triggers Caspase-Dependent Inhibition of Platelet Procoagulant Extracellular Vesicle Release during Apoptosis and Secondary Necrosis In Vitro.
Wei H; Harper MT
Thromb Haemost; 2019 Oct; 119(10):1665-1674. PubMed ID: 31493778
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritis.
Lawlor KE; Smith SD; van Nieuwenhuijze A; Huang DC; Wicks IP
J Leukoc Biol; 2011 Oct; 90(4):819-29. PubMed ID: 21719460
[TBL] [Abstract][Full Text] [Related]
24. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells.
Kim BM; Choi YJ; Han Y; Yun YS; Hong SH
Toxicol Appl Pharmacol; 2009 Aug; 239(1):87-97. PubMed ID: 19481559
[TBL] [Abstract][Full Text] [Related]
25. Concurrent and separate inside-out transition of platelet apoptosis and activation markers to the platelet surface.
Mutlu A; Gyulkhandanyan AV; Freedman J; Leytin V
Br J Haematol; 2013 Nov; 163(3):377-84. PubMed ID: 24033315
[TBL] [Abstract][Full Text] [Related]
26. ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts.
Ugarenko M; Nudelman A; Rephaeli A; Kimura K; Phillips DR; Cutts SM
Biochem Pharmacol; 2010 Feb; 79(3):339-49. PubMed ID: 19737541
[TBL] [Abstract][Full Text] [Related]
27. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets.
Schoenwaelder SM; Jarman KE; Gardiner EE; Hua M; Qiao J; White MJ; Josefsson EC; Alwis I; Ono A; Willcox A; Andrews RK; Mason KD; Salem HH; Huang DC; Kile BT; Roberts AW; Jackson SP
Blood; 2011 Aug; 118(6):1663-74. PubMed ID: 21673344
[TBL] [Abstract][Full Text] [Related]
28. Selective triggering of platelet apoptosis, platelet activation or both.
Gyulkhandanyan AV; Mutlu A; Freedman J; Leytin V
Br J Haematol; 2013 Apr; 161(2):245-54. PubMed ID: 23398569
[TBL] [Abstract][Full Text] [Related]
29. GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.
Zheng L; Yang W; Zhang C; Ding WJ; Zhu H; Lin NM; Wu HH; He QJ; Yang B
Cancer Lett; 2011 Oct; 309(1):27-36. PubMed ID: 21664043
[TBL] [Abstract][Full Text] [Related]
30. Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation.
Bae ON; Lim KM; Noh JY; Chung SM; Kim SH; Chung JH
Toxicol Appl Pharmacol; 2009 Sep; 239(2):144-53. PubMed ID: 19167414
[TBL] [Abstract][Full Text] [Related]
31. [Characterisation of enucleated cells apoptosis: human platelets and erythrocytes].
Mindukshev IV; Rukoiatkina NI; Dobrylko IA; Skverchinskaia EA; Nikitina ER; Krivoshlyk VV; Gambarian SP; Krivchenko AI
Ross Fiziol Zh Im I M Sechenova; 2013 Jan; 99(1):92-110. PubMed ID: 23659060
[TBL] [Abstract][Full Text] [Related]
32. Omi/HtrA2 and XIAP are components of platelet apoptosis signalling.
Winkler J; Rand ML; Schmugge M; Speer O
Thromb Haemost; 2013 Mar; 109(3):532-9. PubMed ID: 23306356
[TBL] [Abstract][Full Text] [Related]
33. Apoptotic markers in human blood platelets treated with peroxynitrite.
Wachowicz B; Rywaniak JZ; Nowak P
Platelets; 2008 Dec; 19(8):624-35. PubMed ID: 19012180
[TBL] [Abstract][Full Text] [Related]
34. Role of mitochondrial permeability transition pore in coated-platelet formation.
Remenyi G; Szasz R; Friese P; Dale GL
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):467-71. PubMed ID: 15591217
[TBL] [Abstract][Full Text] [Related]
35. The molecular basis of synergism between carboplatin and ABT-737 therapy targeting ovarian carcinomas.
Jain HV; Meyer-Hermann M
Cancer Res; 2011 Feb; 71(3):705-15. PubMed ID: 21169413
[TBL] [Abstract][Full Text] [Related]
36. βγ-CAT, a non-lens betagamma-crystallin and trefoil factor complex, induces calcium-dependent platelet apoptosis.
Gao Q; Xiang Y; Chen Z; Zeng L; Ma X; Zhang Y
Thromb Haemost; 2011 May; 105(5):846-54. PubMed ID: 21359407
[TBL] [Abstract][Full Text] [Related]
37. Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists.
Rukoyatkina N; Mindukshev I; Walter U; Gambaryan S
Cell Death Dis; 2013 Nov; 4(11):e931. PubMed ID: 24263105
[TBL] [Abstract][Full Text] [Related]
38. Caspase inhibition decreases both platelet phosphatidylserine exposure and aggregation: caspase inhibition of platelets.
Cohen Z; Wilson J; Ritter L; McDonagh P
Thromb Res; 2004; 113(6):387-93. PubMed ID: 15226093
[TBL] [Abstract][Full Text] [Related]
39. Sorbitol-induced apoptosis of human leukemia is mediated by caspase activation and cytochrome c release.
Marfè G; Morgante E; Di Stefano C; Di Renzo L; De Martino L; Iovane G; Russo MA; Sinibaldi-Salimei P
Arch Toxicol; 2008 Jun; 82(6):371-7. PubMed ID: 18046541
[TBL] [Abstract][Full Text] [Related]
40. Thrombin-triggered platelet apoptosis.
Leytin V; Allen DJ; Mykhaylov S; Lyubimov E; Freedman J
J Thromb Haemost; 2006 Dec; 4(12):2656-63. PubMed ID: 16961585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
